FDA Warning on Xylazine: Mitigating Human Risk | by: Sumeet Singh, Founder & Chairman | Article Posted: November 6, 2023 | The U.S. Food and Drug Administration (FDA) has issued a warning regarding mitigating risks from human Xylazine exposure. FDA has not...
DSCSA to Cause Future State Regulation Changes State regulation of the pharmaceutical supply chain is a patchwork of different definitions,...
The 2,200% increase for Minnesota fees has created an unprecedented barrier to entry for small wholesalers and start-up manufacturers. Of our clients, 25% have decided to forego licensure in the state– typically smaller wholesalers and virtual manufacturers who have not yet started a business within the state.
Even as the COVID-19 pandemic disrupts day-to-day life, drug pricing transparency rages on between consumer groups, regulators, and industry. Regulators are now having to resort to assessing significant fines to increase compliance.
Pharma Solutions Submits Comments on New PR Rule Pharma Solutions is making public comments on the Puerto Rico Department of Health’s proposed...
Pharma Solutions continues to stay on top of developments with the Puerto Rico Department of Health’s portal. In early April 2020, issues with their technology provider brought the entire web portal down, preventing submission for both drug registrations and controlled substance licensing.
AmerisourceBergen Reprimanded for Ineffective Suspicious Order Monitoring The settlement between the California Board of Pharmacy and...
